Breaking News

PAREXEL, Datavant in RWE Alliance

Aims to link healthcare data from a variety of real-world and clinical study data sources to improve drug development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PAREXEL International Corp. and Datavant, Inc., a healthcare technology company focused on enabling the secure de-identification and linking of healthcare datasets, have partnered to enhance clinical study design and operations, as well as the generation of real-world evidence. The collaboration aims to enable the linking of healthcare data from a variety of real-world and clinical study data sources to improve drug development and commercialization processes.   Datavant’s technology enables t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters